Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV lidocaine before extubation for prevention of post-extubation laryngospasm in children undergoing adenotonsillectomy
ACTRN12626000346370Phase 4Not yet recruiting
- Sponsor
- Tamer Group
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine in laryngismus (2 arms), sponsored by Tamer Group. Primary endpoint: Occurrence of laryngospasm after extubation. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
laryngismus
Beyond the preview
Go deeper on ACTRN12626000346370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000346370.